Max Wolff

1.1k total citations
34 papers, 533 citations indexed

About

Max Wolff is a scholar working on Clinical Psychology, Cognitive Neuroscience and Experimental and Cognitive Psychology. According to data from OpenAlex, Max Wolff has authored 34 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Clinical Psychology, 11 papers in Cognitive Neuroscience and 11 papers in Experimental and Cognitive Psychology. Recurrent topics in Max Wolff's work include Psychedelics and Drug Studies (15 papers), Behavioral Health and Interventions (10 papers) and Chemical synthesis and alkaloids (10 papers). Max Wolff is often cited by papers focused on Psychedelics and Drug Studies (15 papers), Behavioral Health and Interventions (10 papers) and Chemical synthesis and alkaloids (10 papers). Max Wolff collaborates with scholars based in Germany, Denmark and United States. Max Wolff's co-authors include Thomas Goschke, Klaus‐Martin Krönke, Anja Kräplin, Michael N. Smolka, Gerhard Bühringer, Lea J. Mertens, Ricarda Evens, Gerhard Gründer, Henrik Jungaberle and Michael Koslowski and has published in prestigious journals such as Psychological Review, Psychological Science and Neuropsychologia.

In The Last Decade

Max Wolff

30 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Wolff Germany 14 280 155 140 136 127 34 533
Paul Liknaitzky Australia 12 278 1.0× 72 0.5× 26 0.2× 122 0.9× 84 0.7× 31 463
Thomas Anderson Canada 10 380 1.4× 62 0.4× 111 0.8× 236 1.7× 16 0.1× 18 498
Stephanie Müller United States 6 277 1.0× 132 0.9× 116 0.8× 52 0.4× 25 0.2× 8 429
Ricarda Evens Germany 12 231 0.8× 42 0.3× 109 0.8× 118 0.9× 10 0.1× 19 412
Jared R. Lindahl United States 12 735 2.6× 286 1.8× 183 1.3× 39 0.3× 80 0.6× 21 850
Dominique P. Lippelt Netherlands 6 262 0.9× 99 0.6× 151 1.1× 76 0.6× 28 0.2× 7 409
Richard J. Zeifman Canada 18 739 2.6× 80 0.5× 29 0.2× 374 2.8× 18 0.1× 43 806
Joy H. Wymer United States 6 345 1.2× 61 0.4× 77 0.6× 77 0.6× 11 0.1× 6 506
Martin Andersson Sweden 12 138 0.5× 40 0.3× 118 0.8× 58 0.4× 16 0.1× 16 434
Sharon L. Lo United States 11 201 0.7× 104 0.7× 70 0.5× 47 0.3× 27 0.2× 25 377

Countries citing papers authored by Max Wolff

Since Specialization
Citations

This map shows the geographic impact of Max Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Wolff more than expected).

Fields of papers citing papers by Max Wolff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Wolff. The network helps show where Max Wolff may publish in the future.

Co-authorship network of co-authors of Max Wolff

This figure shows the co-authorship network connecting the top 25 collaborators of Max Wolff. A scholar is included among the top collaborators of Max Wolff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Wolff. Max Wolff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wolff, Max, et al.. (2025). Key competencies for psychedelic treatment in real-world mental health care settings. General Hospital Psychiatry. 97. 11–24. 1 indexed citations
4.
Wolff, Max, Natalie Gukasyan, Leor Roseman, & Paul Liknaitzky. (2025). Reframing psychedelic regulation: Tools, not treatments. 11. 1 indexed citations
5.
Evens, Ricarda & Max Wolff. (2024). Die Rolle der Psychotherapie in klinischen Studien mit Psychedelika. 69(2). 85–91. 1 indexed citations
6.
Wolff, Max, Ricarda Evens, Lea J. Mertens, et al.. (2024). Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ). Journal of Psychopharmacology. 38(5). 432–457. 16 indexed citations
7.
Aicher, Helena, Max Wolff, & Uwe Herwig. (2024). Psychedelic therapy – refining the claim of a paradigm shift. International Review of Psychiatry. 36(8). 920–927. 2 indexed citations
8.
Gründer, Gerhard, et al.. (2023). Treatment with psychedelics is psychotherapy: beyond reductionism. The Lancet Psychiatry. 11(3). 231–236. 54 indexed citations
9.
Seidel, Maria, Stefan Diestel, Max Wolff, et al.. (2022). Real-life self-control conflicts in anorexia nervosa: An ecological momentary assessment investigation. European Psychiatry. 65(1). e39–e39. 2 indexed citations
10.
Schmidt, Christopher W., Max Wolff, Gerhard Gründer, & Henrik Jungaberle. (2022). Einstellungen von Expertinnen und Experten für psychische Gesundheit gegenüber Psilocybin. Fortschritte der Neurologie · Psychiatrie. 91(3). 80–87. 3 indexed citations
11.
Mertens, Lea J., Michael Koslowski, Felix Betzler, et al.. (2022). Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) – Rationale and study design. Neuroscience Applied. 1. 100104–100104. 24 indexed citations
13.
Gärtner, Anne, et al.. (2021). No relation of Need for Cognition to basic executive functions. Journal of Personality. 89(6). 1113–1125. 14 indexed citations
14.
Dieterich, Raoul, et al.. (2021). The Error-Related Negativity Predicts Self-Control Failures in Daily Life. Frontiers in Human Neuroscience. 14. 614979–614979. 19 indexed citations
15.
Krönke, Klaus‐Martin, Holger Mohr, Max Wolff, et al.. (2021). Real-Life Self-Control is Predicted by Parietal Activity During Preference Decision Making: A Brain Decoding Analysis. Cognitive Affective & Behavioral Neuroscience. 21(5). 936–947. 8 indexed citations
16.
Wolff, Max, Ricarda Evens, Lea J. Mertens, et al.. (2020). Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance. Frontiers in Psychiatry. 11. 5–5. 94 indexed citations
17.
Kräplin, Anja, Michael Höfler, Shakoor Pooseh, et al.. (2020). Impulsive decision-making predicts the course of substance-related and addictive disorders. Psychopharmacology. 237(9). 2709–2724. 27 indexed citations
18.
Krönke, Klaus‐Martin, Max Wolff, Anja Kräplin, et al.. (2020). Functional connectivity in a triple-network saliency model is associated with real-life self-control. Neuropsychologia. 149. 107667–107667. 39 indexed citations
19.
Krönke, Klaus‐Martin, Max Wolff, Holger Mohr, et al.. (2018). Monitor yourself! Deficient error-related brain activity predicts real-life self-control failures. Cognitive Affective & Behavioral Neuroscience. 18(4). 622–637. 31 indexed citations
20.
Wolff, Max, Klaus‐Martin Krönke, John Venz, et al.. (2016). Action versus state orientation moderates the impact of executive functioning on real-life self-control.. Journal of Experimental Psychology General. 145(12). 1635–1653. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026